CompoAtlas

JAMP-Urea 22

Natural health product licensed in Canada

Other names
JamUrea22
Licence holder
JAMP Pharma Corporation
NPN or DIN-HM
80116742
Status
Active licence
Licence date
25 February 2022
Revision date
24 August 2026
Form
Crème
Route of administration
Topique
Application type
Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Hydroxyde de sodium, Octyldodécanol, Triglycéride caprylique/caprique, Eau purifiée, Diazolidinyl urée, Stéarates de glycéryle, Cétéareth-12, Cétéareth-20, (p)-hydroxybenzoate de propyle, Propylène glycol, Parfum, (p)-hydroxybenzoate de méthyle

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve the symptoms of dry and thickened skin conditions (such as ichthyosis and xerosis).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80116742

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line